Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979894975> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2979894975 abstract "Abstract Background Experimental data are consistent with the hypothesis that activation of the PDGF receptor (PDGFR) is characteristic of scleroderma (SSc) fibroblasts and may contribute to their activation. We have recently demonstrated that fibroblasts from SSc patients contain high Ha Ras and ROS (Reactive Oxygen Species) levels and constitutive activation of ERK1/2 (Svegliati et al: JBC in press). Furthermore, SSc patients have circulating auto-antibodies against the PDGFR which induce type I collagen gene expression in normal human fibroblasts through the Ha Ras-ERK1/2- ROS pathway (Svegliati et al: Submitted). These findings suggest that anti PDGFR auto-antibodies play a pivotal role in the pathogenesis of scleroderma. Clinical chronic graft-versus-host disease (cGVHD) can show manifestations that are very similar to those of SSc. Although it is conceivable that the two diseases can share a similar pathophysiological mechanism there are no data supporting this assumption. In view of these considerations we tested the hypothesis that patients with cGVHD have serum auto-antibodies that stimulate PDGFR and activate collagen gene expression in fibroblasts. Methods Serum from 7 patients with extensive cGVHD showing scleroderma-like features either in the skin or in the lung was analyzed for the presence of stimulatory autoantibodies to PDGFR. Patients receiving allogeneic transplantation, but without any signs of cGVHD were used as controls. The median F-U after transplant was 23 months (range 16–36) in patients with cGVH and 42 (range 9–51) in the control group. The assay was carried by incubating purified IgG of the patients with mouse embryo fibroblasts carrying inactive copies of PDGFR α or β chains (PDGFR −/−) or the same cells expressing PDGFR α or β, respectively. Production of reactive oxygen species was assayed in the presence or absence of specific PDGFR inhibitors. The antibodies were characterized by immunoprecipitation, immunoblotting and absorption experiments in primary human fibroblasts and endothelial cells. Result Stimulatory antibodies to the PDGFR were selectively found in all patients with cGVHD and fibrotic lesions. The antibodies specifically recognized PDGFR, induced tyrosine phosphorylation and ROS accumulation. Their activity was completely and selectively abolished by pre-incubation with cells expressing PDGFR α or β chains or by PDGF receptor tyrosine kinase inhibitor. Anti-PDGFR antibodies induced selectively Ha-Ras-ERK1/2 and ROS cascade and stimulated the expression of type I collagen gene and myofibroblast phenotype conversion in normal human primary fibroblasts. Antibodies were absent in all controls. Conclusions Stimulatory auto-antibodies against PDGFR represent a specific hallmark of patients with cGVHD. Their biological activity on fibroblasts strongly argues for a causal role in the pathogenesis of the disease." @default.
- W2979894975 created "2019-10-18" @default.
- W2979894975 creator A5014301731 @default.
- W2979894975 creator A5022330993 @default.
- W2979894975 creator A5024306596 @default.
- W2979894975 creator A5043533199 @default.
- W2979894975 creator A5069066410 @default.
- W2979894975 creator A5075520151 @default.
- W2979894975 creator A5079896587 @default.
- W2979894975 creator A5088147792 @default.
- W2979894975 date "2005-11-16" @default.
- W2979894975 modified "2023-10-14" @default.
- W2979894975 title "Stimulatory Auto-Antibodies to the PDGF Receptor in Patients with Chronic GVHD." @default.
- W2979894975 doi "https://doi.org/10.1182/blood.v106.11.454.454" @default.
- W2979894975 hasPublicationYear "2005" @default.
- W2979894975 type Work @default.
- W2979894975 sameAs 2979894975 @default.
- W2979894975 citedByCount "0" @default.
- W2979894975 crossrefType "journal-article" @default.
- W2979894975 hasAuthorship W2979894975A5014301731 @default.
- W2979894975 hasAuthorship W2979894975A5022330993 @default.
- W2979894975 hasAuthorship W2979894975A5024306596 @default.
- W2979894975 hasAuthorship W2979894975A5043533199 @default.
- W2979894975 hasAuthorship W2979894975A5069066410 @default.
- W2979894975 hasAuthorship W2979894975A5075520151 @default.
- W2979894975 hasAuthorship W2979894975A5079896587 @default.
- W2979894975 hasAuthorship W2979894975A5088147792 @default.
- W2979894975 hasConcept C10162356 @default.
- W2979894975 hasConcept C126322002 @default.
- W2979894975 hasConcept C142724271 @default.
- W2979894975 hasConcept C159654299 @default.
- W2979894975 hasConcept C163764329 @default.
- W2979894975 hasConcept C170493617 @default.
- W2979894975 hasConcept C180032290 @default.
- W2979894975 hasConcept C180361614 @default.
- W2979894975 hasConcept C203014093 @default.
- W2979894975 hasConcept C2775960820 @default.
- W2979894975 hasConcept C2776670291 @default.
- W2979894975 hasConcept C2779075594 @default.
- W2979894975 hasConcept C2779967694 @default.
- W2979894975 hasConcept C2780942790 @default.
- W2979894975 hasConcept C71924100 @default.
- W2979894975 hasConcept C86803240 @default.
- W2979894975 hasConceptScore W2979894975C10162356 @default.
- W2979894975 hasConceptScore W2979894975C126322002 @default.
- W2979894975 hasConceptScore W2979894975C142724271 @default.
- W2979894975 hasConceptScore W2979894975C159654299 @default.
- W2979894975 hasConceptScore W2979894975C163764329 @default.
- W2979894975 hasConceptScore W2979894975C170493617 @default.
- W2979894975 hasConceptScore W2979894975C180032290 @default.
- W2979894975 hasConceptScore W2979894975C180361614 @default.
- W2979894975 hasConceptScore W2979894975C203014093 @default.
- W2979894975 hasConceptScore W2979894975C2775960820 @default.
- W2979894975 hasConceptScore W2979894975C2776670291 @default.
- W2979894975 hasConceptScore W2979894975C2779075594 @default.
- W2979894975 hasConceptScore W2979894975C2779967694 @default.
- W2979894975 hasConceptScore W2979894975C2780942790 @default.
- W2979894975 hasConceptScore W2979894975C71924100 @default.
- W2979894975 hasConceptScore W2979894975C86803240 @default.
- W2979894975 hasLocation W29798949751 @default.
- W2979894975 hasOpenAccess W2979894975 @default.
- W2979894975 hasPrimaryLocation W29798949751 @default.
- W2979894975 hasRelatedWork W1983203756 @default.
- W2979894975 hasRelatedWork W2002898746 @default.
- W2979894975 hasRelatedWork W2029980802 @default.
- W2979894975 hasRelatedWork W2041944852 @default.
- W2979894975 hasRelatedWork W2101875571 @default.
- W2979894975 hasRelatedWork W2158167954 @default.
- W2979894975 hasRelatedWork W2402784173 @default.
- W2979894975 hasRelatedWork W2405627905 @default.
- W2979894975 hasRelatedWork W2413820678 @default.
- W2979894975 hasRelatedWork W325933835 @default.
- W2979894975 isParatext "false" @default.
- W2979894975 isRetracted "false" @default.
- W2979894975 magId "2979894975" @default.
- W2979894975 workType "article" @default.